These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30273338)

  • 1. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
    Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
    PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
    Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
    J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
    da Mata S; Ferreira J; Nicolás I; Esteves S; Esteves G; Lérias S; Silva F; Saco A; Cochicho D; Cunha M; Del Pino M; Ordi J; Félix A
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
    Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
    Int J Gynecol Cancer; 2001; 11(1):39-48. PubMed ID: 11285032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus Infection Determines Prognosis in Cervical Cancer.
    Lei J; Arroyo-Mühr LS; Lagheden C; Eklund C; Nordqvist Kleppe S; Elfström M; Andrae B; Sparén P; Dillner J; Sundström K
    J Clin Oncol; 2022 May; 40(14):1522-1528. PubMed ID: 35077203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.
    Sundström K; Ploner A; Arnheim-Dahlström L; Eloranta S; Palmgren J; Adami HO; Ylitalo Helm N; Sparén P; Dillner J
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26160881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
    Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
    Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
    Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
    Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
    BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, survival outcomes, and clinicopathologic factors associated with negative high risk human papillomavirus in surgical specimens of cervical cancer with pretreatment negative DNA genotype test.
    Chong GO; Han HS; Park JY; Lee SD; Lee YH; Lee HJ; Hong DG; Lee YS
    Int J Gynecol Cancer; 2019 Jan; 29(1):10-16. PubMed ID: 30640677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
    Viladiu P; Bosch FX; Castellsagué X; Muñoz N; Escribà JM; Hamsíkova E; Hofmannova V; Guerrero E; Izquierdo A; Navarro C; Moreo P; Izarzugaza I; Ascunce N; Gili M; Muñoz MT; Tafur L; Shah KV; Vonka V
    J Clin Oncol; 1997 Feb; 15(2):610-9. PubMed ID: 9053484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of human papillomavirus and risk of cervical adenocarcinoma.
    Dahlström LA; Ylitalo N; Sundström K; Palmgren J; Ploner A; Eloranta S; Sanjeevi CB; Andersson S; Rohan T; Dillner J; Adami HO; Sparén P
    Int J Cancer; 2010 Oct; 127(8):1923-30. PubMed ID: 20473898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.
    Franceschi S; Rajkumar T; Vaccarella S; Gajalakshmi V; Sharmila A; Snijders PJ; Muñoz N; Meijer CJ; Herrero R
    Int J Cancer; 2003 Oct; 107(1):127-33. PubMed ID: 12925967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study.
    Franco E; Bergeron J; Villa L; Arella M; Richardson L; Arseneau J; Stanimir G
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):271-5. PubMed ID: 8722218
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.